Characterization:novel genotoxic stress-regulated gene

表征:新型遗传毒性应激调节基因

基本信息

  • 批准号:
    7030099
  • 负责人:
  • 金额:
    $ 22.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-03-01 至 2008-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Cells are constantly exposed to a variety of environmental agents some of which induce DNA damage i.e. genotoxic stress. Cellular responses to genotoxic stress are complex and therefore, more studies are needed to better understand the mechanisms that control such responses. Here we propose to characterize a novel gene, which we have named PIQ (p53-regulated IQ protein) that codes for an IQ motif protein. IQ motifs promote protein interactions with calmodulin (CaM). CaM is a calcium-binding protein that controls several important signaling events. Evidence presented here show that PIQ does indeed bind to CaM. Furthermore, PIQ mRNA is overexpressed in primary colon tumors when compared with matching normal tissues and that PIQ is down-regulated in response to genotoxic stress and p53 activation. PUMA is a key mediator of p53- dependent genotoxic stress-induced apoptosis and our results indicate that PIQ down-regulates PUMA promoter expression. Importantly, PUMA promoter harbors regulatory elements that are predicted to be regulated by CaM-dependent signaling pathways. We, therefore, propose that in unstressed cells, PIQ may negatively regulate PUMA expression by interfering with CaM-dependent signaling events and PIQ downregulation following genotoxic stress serves to promote PUMA upregulation partly via CaM-dependent pathways. Our overall hypothesis is that PIQ is a negative modulator of apoptosis and that higher levels of PIQ expression noted in colon cancer may alter the threshold of apoptosis and consequently contribute in part to colon tumorigenesis. Three specific aims are proposed here to further characterize PIQ in order to elucidate its role in cellular response to genotoxic stress in general and in the development and/or progression of colon cancer in particular. Specific Aim 1 is to investigate the role of PIQ during p53 and genotoxic stress-induced apoptosis. Specific Aim 2 is to investigate the mechanism by which PIQ negatively regulates PUMA promoter expression. Specific Aim 3 is to analyze PIQ expression at the mRNA and protein levels in a larger pool of primary colon tumors and their matching normal tissues and to evaluate a relationship between tumor PIQ-status and the clinicopathologic features.
描述(由申请人提供):细胞持续暴露于各种环境因子,其中一些可诱导DNA损伤,即遗传毒性应激。细胞对遗传毒性应激的反应是复杂的,因此,需要更多的研究来更好地了解控制这种反应的机制。在这里,我们提出了一个新的基因,我们命名为PIQ(p53调节的智商蛋白),编码的智商基序蛋白。IQ基序促进蛋白质与钙调蛋白(CaM)的相互作用。CaM是一种钙结合蛋白,控制着几个重要的信号事件。这里提出的证据表明,PIQ确实与钙调素结合。此外,与匹配的正常组织相比,PIQ mRNA在原发性结肠肿瘤中过表达,并且PIQ响应于遗传毒性应激和p53激活而下调。p53依赖性基因毒性应激诱导的细胞凋亡中,p53依赖性基因毒性应激诱导的细胞凋亡重要的是,CD 4A启动子含有预测由CaM依赖性信号通路调节的调节元件。因此,我们提出,在未应激的细胞中,PIQ可能通过干扰钙调素依赖性信号传导事件来负调控CRAMA表达,而遗传毒性应激后PIQ下调可部分通过钙调素依赖性途径促进CRAMA上调。我们的总体假设是,PIQ是细胞凋亡的负调节因子,结肠癌中较高水平的PIQ表达可能会改变细胞凋亡的阈值,从而部分促进结肠肿瘤的发生。本文提出了三个具体目标,以进一步表征PIQ,以阐明其在细胞对遗传毒性应激反应中的作用,特别是在结肠癌的发生和/或进展中的作用。具体目标1是研究PIQ在p53和遗传毒性应激诱导的细胞凋亡中的作用。具体目标2是研究PIQ负调控CCRIA启动子表达的机制。具体目标3是在原发性结肠肿瘤及其匹配的正常组织的较大池中分析mRNA和蛋白质水平的PIQ表达,并评价肿瘤PIQ状态与临床病理特征之间的关系。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

M. SAEED SHEIKH其他文献

M. SAEED SHEIKH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('M. SAEED SHEIKH', 18)}}的其他基金

Development of dihydroartemisinin as a novel preventive agent for prostate cancer
双氢青蒿素作为前列腺癌新型预防剂的开发
  • 批准号:
    8050362
  • 财政年份:
    2011
  • 资助金额:
    $ 22.8万
  • 项目类别:
Development of dihydroartemisinin as a novel preventive agent for prostate cancer
双氢青蒿素作为前列腺癌新型预防剂的开发
  • 批准号:
    8242022
  • 财政年份:
    2011
  • 资助金额:
    $ 22.8万
  • 项目类别:
A novel biomarker and therapeutic target for breast cancer
乳腺癌的新型生物标志物和治疗靶点
  • 批准号:
    8220835
  • 财政年份:
    2011
  • 资助金额:
    $ 22.8万
  • 项目类别:
A novel biomarker and therapeutic target for breast cancer
乳腺癌的新型生物标志物和治疗靶点
  • 批准号:
    8062885
  • 财政年份:
    2011
  • 资助金额:
    $ 22.8万
  • 项目类别:
Characterization of a novel stress-regulated anti-apoptotic ubiquitin ligase
新型应激调节抗凋亡泛素连接酶的表征
  • 批准号:
    7466107
  • 财政年份:
    2008
  • 资助金额:
    $ 22.8万
  • 项目类别:
Characterization of a novel stress-regulated anti-apoptotic ubiquitin ligase
新型应激调节抗凋亡泛素连接酶的表征
  • 批准号:
    7567486
  • 财政年份:
    2008
  • 资助金额:
    $ 22.8万
  • 项目类别:
PDRG, a novel p53 and DNA damage-regulated gene and colorectal cancer
PDRG,一种新型 p53 和 DNA 损伤调节基因与结直肠癌
  • 批准号:
    7265025
  • 财政年份:
    2007
  • 资助金额:
    $ 22.8万
  • 项目类别:
PDRG, a novel p53 and DNA damage-regulated gene and colorectal cancer
PDRG,一种新型 p53 和 DNA 损伤调节基因与结直肠癌
  • 批准号:
    7426429
  • 财政年份:
    2007
  • 资助金额:
    $ 22.8万
  • 项目类别:
Characterization:novel genotoxic stress-regulated gene
表征:新型遗传毒性应激调节基因
  • 批准号:
    7229934
  • 财政年份:
    2006
  • 资助金额:
    $ 22.8万
  • 项目类别:
COX-2 and p53 interactions and cancer prevention
COX-2 和 p53 相互作用与癌症预防
  • 批准号:
    6804993
  • 财政年份:
    2003
  • 资助金额:
    $ 22.8万
  • 项目类别:

相似海外基金

Investigation of improvement of skeletal muscle function by RNA interference for prevention of frailty
通过 RNA 干扰改善骨骼肌功能预防衰弱的研究
  • 批准号:
    23K10830
  • 财政年份:
    2023
  • 资助金额:
    $ 22.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Tissue Adhesive RNA Interference Nanoparticles to Block Progression of Posttraumatic and Spontaneous Osteoarthritis.
组织粘附 RNA 干扰纳米颗粒可阻止创伤后和自发性骨关节炎的进展。
  • 批准号:
    10539405
  • 财政年份:
    2022
  • 资助金额:
    $ 22.8万
  • 项目类别:
Tissue Adhesive RNA Interference Nanoparticles to Block Progression of Posttraumatic and Spontaneous Osteoarthritis.
组织粘附 RNA 干扰纳米颗粒可阻止创伤后和自发性骨关节炎的进展。
  • 批准号:
    10688080
  • 财政年份:
    2022
  • 资助金额:
    $ 22.8万
  • 项目类别:
Using RNA interference to combat the worst emerging disease of wildlife
利用 RNA 干扰对抗野生动物最严重的新疾病
  • 批准号:
    DP220101361
  • 财政年份:
    2022
  • 资助金额:
    $ 22.8万
  • 项目类别:
    Discovery Projects
RNA Interference and Heterochromatic Silencing in Replication and Quiescence
复制和静止过程中的 RNA 干扰和异染色质沉默
  • 批准号:
    10677770
  • 财政年份:
    2022
  • 资助金额:
    $ 22.8万
  • 项目类别:
Regulation of RNA interference pathways by extracellular cues
细胞外信号对 RNA 干扰途径的调节
  • 批准号:
    RGPIN-2019-04411
  • 财政年份:
    2022
  • 资助金额:
    $ 22.8万
  • 项目类别:
    Discovery Grants Program - Individual
CAREER: Investigating the Role of an RNA Interference Pathway in Safeguarding the Tetrahymena Thermophila Somatic Genome
职业:研究 RNA 干扰途径在保护嗜热四膜虫体细胞基因组中的作用
  • 批准号:
    2143019
  • 财政年份:
    2022
  • 资助金额:
    $ 22.8万
  • 项目类别:
    Continuing Grant
New Cancer Therapy: A Combination of RNA Interference and Gene Therapy
新的癌症疗法:RNA干扰和基因疗法的结合
  • 批准号:
    486535
  • 财政年份:
    2022
  • 资助金额:
    $ 22.8万
  • 项目类别:
    Studentship Programs
RNA Interference and Heterochromatic Silencing in Replication and Quiescence
复制和静止过程中的 RNA 干扰和异染色质沉默
  • 批准号:
    10330828
  • 财政年份:
    2022
  • 资助金额:
    $ 22.8万
  • 项目类别:
CAREER: Abiotic degradation of emerging RNA interference pesticides
职业:新兴 RNA 干扰农药的非生物降解
  • 批准号:
    2046602
  • 财政年份:
    2021
  • 资助金额:
    $ 22.8万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了